Heparin versus aspirin in ischaemic stroke (multiple letters)

Lancet

Volumn 356, Issue 9228, 2000, Pages 504-505

  Toni, D ^a   Argentino, C ^a   Fieschi, C ^a   Pereira, A C ^a   Warburton, E ^a   Berge, E ^a   Sandset, P M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; GLUCOSE; LOW MOLECULAR WEIGHT HEPARIN; FIBRINOLYTIC AGENT;

ANTICOAGULATION; BODY TEMPERATURE; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; PRIORITY JOURNAL; RECURRENCE RISK; STROKE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; DISEASE COURSE; NOTE; RECURRENT DISEASE;

ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; DISEASE PROGRESSION; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; RECURRENCE;

MLCS; MLOWN;

EID: 0034609067     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)